RenovoRx, Inc. — Investor Relations & Filings
Filings indexed
260
across all filing types
Latest filing
2026-05-15
Annual Report
Country
US
United States of America
Listing
US
RNXT
RenovoRx, Inc. is a clinical-stage life sciences company developing targeted oncology therapies for solid tumors. The company's core technology is its proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform, which is designed for the localized delivery of therapeutic agents directly to tumors. This approach aims to enhance treatment efficacy while minimizing the systemic toxicities associated with conventional intravenous chemotherapy. The TAMP platform is enabled by the RenovoCath®, an FDA-cleared dual-balloon infusion catheter that isolates blood flow for targeted drug delivery. RenovoRx is advancing its lead drug-device combination product candidate in the Phase III TIGeR-PaC clinical trial for the treatment of locally advanced pancreatic cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K/A | 2026-05-15 | English | |
| 8-K | 2026-05-14 | English | |
| DEF 14A - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-30 | English | |
| 424B3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-27 | English | |
| S-3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-16 | English | |
| 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46363239 | 10-K/A | 2026-05-15 | English | ||
| 46274549 | 8-K | 2026-05-14 | English | ||
| 39207996 | DEF 14A - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-30 | English | ||
| 37646430 | 424B3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-27 | English | ||
| 34650376 | S-3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-16 | English | ||
| 33058807 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English | ||
| 33058608 | 3/A - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English | ||
| 33058261 | 8-K - RenovoRx, Inc. (0001574094) (Filer) | 2026-03-27 | English | ||
| 33036308 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036307 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036306 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036294 | 3 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33012729 | 8-K - RenovoRx, Inc. (0001574094) (Filer) | 2026-03-23 | English | ||
| 30649394 | 8-K Filing | 2026-02-06 | English | ||
| 30649391 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
RenovoRx, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34656/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34656 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34656 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34656 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34656}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RenovoRx, Inc. (id: 34656)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.